Abstract
Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In this first of 5 sections of the guidelines of care for psoriasis, we discuss the classification of psoriasis; associated comorbidities including autoimmune diseases, cardiovascular risk, psychiatric/psychologic issues, and cancer risk; along with assessment tools for skin disease and quality-of-life issues. Finally, we will discuss the safety and efficacy of the biologic treatments used to treat patients with psoriasis.
Original language | English |
---|---|
Pages (from-to) | 826-850 |
Number of pages | 25 |
Journal | Journal of the American Academy of Dermatology |
Volume | 58 |
Issue number | 5 |
DOIs | |
State | Published - May 2008 |